Unmasking of normocalcemic primary hyperparathyroidism after sodium-glucose cotransporter-2 inhibitor initiation

Unmasking of normocalcemic primary hyperparathyroidism after sodium-glucose cotransporter-2 inhibitor initiation

Sodium-glucose cotransporter-2 (SGLT2) inhibitors have complex interactions with bone metabolism, including an increase in parathyroid hormone (PTH) levels. Here we report a case of a SGLT2 inhibitor-induced hypercalcemia due to primary hyperparathyroidism. In the subset of patients with normocalcem...

Full description

Saved in:
Bibliographic Details
Main Authors: Christodoulos Dolapsakis, Emmanouil Karofylakis, Stamatios Chalvatzis
Format: Article
Language:English
Published: SMC MEDIA SRL 2025-01-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
sglt2 inhibitors
hypercalcemia
hyperparathyroidism
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/5169
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items